Concerns with GLP-1 Supply (Tirzepatide and Semaglutide)

Tirzepatide:

Date: 03/06/2025

On March 5th, 2025, the judge overseeing the OFA v. FDA denied the plaintiff’s request for a preliminary injunction to allow for compounded Tirzepatide, which means that, as it stands, the FDA's enforcement discretion will remain in effect until March 19th, 2025. However, there is a possibility that the OFA may appeal this ruling, which could impact the timeline for dispensing.

As a result, it appears that NextGenRx will not be able to dispense Tirzepatide after March 19th, 2025. We strongly recommend that you prepare for this stoppage by securing your medication refill as soon as possible (no later than: 3/13/2025).

What This Means for Our Customers:

1. Immediate Action Required: We urge all patients to submit their refill request for Tirzepatide formulations immediately. Given the uncertainty surrounding the appeal process, it is crucial to act quickly.
2. Order Fulfillment Timeline: Please note that we will not be able to refill orders for Tirzepatide after March 19th, 2025, unless we receive further updates from the courts.
3. Increased Demand: Our team is experiencing a significant increase in demand, and while we are committed to keeping you informed about your order status and addressing any specific questions, please be patient as response times may be longer than usual. To reserve the number of vials you would like to refill, please email us at refills@mynextgenrx.com as soon as possible. In your email, include your full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number, and the number of vials you wish to reserve. Please remember that prepayment will be required for these prescriptions.

Thank you for your understanding and cooperation during this time. We are here to support you and will keep you updated on any further developments.

Date: 02/11/2025

On 02/11/2025 the FDA clarified their position on their intentions for enforcement discretion relating to the dispensing of Tirzepatide containing compounded injectables to allow dispensing until either 03/19/2025 or until the date of the district court’s decision on the plaintiffs’ preliminary injunction motion in OFA v. FDA whichever is longer. As such, NextGenRx will continue to dispense Tirzepatide containing compounded injectable medications until the later of 03/19/2025 or a date to be determined by the courts.

Our recommendation for you is to secure as much medication as feasible for you by ordering a refill of the number of vials you and your physician approve of by March 11th, 2025. We will likely be supplying these medications beyond this 03/19/2025, however, we are all at the mercy of the courts.

To better serve you, please email: refills@mynextgenrx.com to reserve the number of vials you would like to refill as soon as possible. In your email please provide: full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number and the number of vials you would like to reserve. We will require prepayment of these prescriptions.

Date: 12/19/2024

On 12/19/24 the FDA removed the brand name drugs: Mounjaro and Zepbound from the drug shortage list. As such, NextGenRx can dispense the compounded version: Tirzepatide until 3/19/2025. Our supplier would like us to provide them with an estimate of how many vials we would like to purchase.

To better serve you, please email: refills@mynextgenrx.com to reserve the number of vials you would like to refill as soon as possible. In your email please provide: Name, date of birth, best contact phone number and the number of vials you would like to reserve. We will require prepayment of these prescriptions.

Semaglutide:

Date: 02/21/2025

On 02/21/2025 the FDA removed the brand name drugs: Ozempic and Wegovy from the drug shortage list. As such, NextGenRx can dispense the compounded version: Semaglutide until 05/22/2025. Our supplier would like us to provide them with an estimate of how many vials we would like to purchase. To best serve you, please continue to order refills of your semaglutide as you usually do until April 15th, 2025.

On or after April 15th, 2025, please consider “stocking up” on your semaglutide injectable prescriptions by sending us an email to: refills@mynextgenrx.com to reserve the number of vials you would like. In your email please provide: full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number, and the number of vials you would like to reserve. We will require prepayment of these prescriptions.